BISMARCK, N.D. –– House Bill 1283 was given a 4-1 Do Not Pass by the North Dakota Senate Business and Industry Committee on Monday following passage in the House. The bill would put North Dakotans one step closer to the peace of mind they need when it comes to breast cancer diagnostics.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients had out-of-pocket costs for follow-up breast cancer diagnostic tests in 2023.
Survivors and oncology professionals share their stories with lawmakers to underscore the importance of insurance coverage of cutting-edge biomarker testing
Insurance coverage of biomarker testing will reduce health disparities for cancer patients & improve outcomes across broad spectrum of serious disease
This afternoon, the New York State Senate unanimously passed legislation that would eliminate cost-sharing for lung cancer screenings and follow-up tests for all eligible New Yorkers insured through a state-regulated health plan, including Medicaid. Senate Bill 2000, sponsored by Senator Joseph Addabbo, received sweeping, bipartisan support and the backing of a coalition of patient advocates, medical leaders and public health organizations.
In a new, large national study published today in the Journal of the American Medical Association (JAMA) Network Open, American Cancer Society (ACS) researchers found the 2018 federal policy loosening restrictions on STLD insurance plans was associated with an increase in late-stage cancer diagnoses in states without or with inadequate additional STLD plan regulatory protections.
Last week, the Senate and House voted to advance Senate Bill 773 and House Bill 1246, legislation which seeks to create more stability for patients by curbing an unfair insurance practice that makes critical medication more expensive and access unpredictable. The passage of each bill in their respective chambers, which now await concurrence voting, came on the heels of the American Cancer Society Cancer Action Network’s (ACS CAN) annual Cancer Action Day when cancer survivors, patient advocates and medical professionals traveled to Annapolis to discuss the importance of this legislation in ensuring access to lifesaving prescription drugs. Advocates are hopeful that lawmakers see the bills’ momentum as a call to action to take the final steps to pass and enact the necessary reforms.
Volunteer advocates, including cancer survivors, patients,
A statement from John Manna, Jr., Esq., Vice Chair of the American Cancer Society Cancer Action Network Board of Directors and constituent of former U.S. Rep. Nita Lowey, on her passing.